pindolol has been researched along with digoxin in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (40.00) | 18.7374 |
| 1990's | 2 (8.00) | 18.2507 |
| 2000's | 5 (20.00) | 29.6817 |
| 2010's | 8 (32.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Bergström, CA; Matsson, P; Nagahara, N; Norinder, U; Tavelin, S | 1 |
| Abraham, MH; Acree, WE; Ibrahim, A | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ohnhaus, EE | 1 |
| Bachour, G; Bender, F; Hochrein, H | 1 |
| Beck, OA; Hochrein, H; Oeff, M | 1 |
| Reiffel, JA | 1 |
| Channer, KS; James, MA; Papouchado, M; Rees, JR | 1 |
| Channer, KS; James, M | 1 |
| Dalal, S; Gupta, MC; Mathur, KS | 1 |
| Banerji, K; Bisht, DB | 1 |
| Bran, M; De Marneffe, M; Denolin, H; Salhadin, P | 1 |
| Moulopoulos, SD; Nanas, JN; Papalambrou, J; Sideris, DA | 1 |
| Camm, J; Martin, A; Wang, R; Ward, D; Washington, H | 1 |
| Channer, KS; James, MA; MacConnell, T; Rees, JR | 1 |
| Del Giaccio, A; Eblen-Zajjur, A | 1 |
3 review(s) available for pindolol and digoxin
| Article | Year |
|---|---|
Membrane transporters in drug development.
Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs | 2010 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Dosage of digitalis glycosides and beta blockers in renal insufficiency].
Topics: Adrenergic beta-Antagonists; Creatinine; Digitalis Glycosides; Digoxin; Humans; Kidney Failure, Chronic; Pindolol; Practolol; Propranolol | 1976 |
4 trial(s) available for pindolol and digoxin
| Article | Year |
|---|---|
Improved control of atrial fibrillation with combined pindolol and digoxin therapy.
Topics: Adult; Aged; Atrial Fibrillation; Digoxin; Drug Therapy, Combination; Dyspnea; Female; Heart Rate; Humans; Middle Aged; Pindolol; Verapamil | 1989 |
Treatment of chronic atrial fibrillation in the elderly, assessed by ambulatory electrocardiographic monitoring.
Topics: Aged; Atrial Fibrillation; Digoxin; Drug Tolerance; Electrocardiography; Evaluation Studies as Topic; Female; Heart Rate; Humans; Male; Middle Aged; Pindolol; Placebos; Verapamil | 1980 |
Beta-adrenoceptor blockers in atrial fibrillation: the importance of partial agonist activity.
Topics: Adrenergic beta-Antagonists; Aged; Analysis of Variance; Atenolol; Atrial Fibrillation; Bradycardia; Digoxin; Drug Synergism; Drug Therapy, Combination; Female; Heart Rate; Humans; Male; Middle Aged; Pindolol; Single-Blind Method | 1994 |
Cardiovascular drugs in human mechanical nociception: digoxin, amlodipine, propranolol, pindolol and atenolol.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Atenolol; Cardiovascular Diseases; Cross-Sectional Studies; Digoxin; Female; Humans; Male; Middle Aged; Nociceptors; Pindolol; Propranolol; Young Adult | 2010 |
18 other study(ies) available for pindolol and digoxin
| Article | Year |
|---|---|
Exploring the role of different drug transport routes in permeability screening.
Topics: Administration, Oral; Biological Transport; Caco-2 Cells; Cell Line; Humans; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Membranes, Artificial; Models, Biological; Molecular Conformation; Monte Carlo Method; Permeability; Pharmaceutical Preparations; Pharmacokinetics | 2005 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
[Hemodynamics after prindolol and digitalis in acute myocardial infarction (author's transl)].
Topics: Acute Disease; Adult; Aged; Blood Pressure; Cardiac Complexes, Premature; Cardiac Output; Digitalis Glycosides; Digoxin; Female; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Pindolol; Pulmonary Artery; Shock, Cardiogenic; Tachycardia; Time Factors; Vascular Resistance | 1976 |
[Influence of digitalis on pindolol activity in exercise-induced cardiac failure in patients with coronary disease (author's transl)].
Topics: Acetyldigoxins; Aged; Blood Pressure; Capillaries; Coronary Disease; Digoxin; Drug Interactions; Female; Humans; Lung; Male; Middle Aged; Pindolol; Pulmonary Artery | 1979 |
Improved rate control in atrial fibrillation.
Topics: Atrial Fibrillation; Digoxin; Drug Evaluation; Drug Therapy, Combination; Electrocardiography, Ambulatory; Heart Rate; Humans; Pindolol | 1992 |
Pindolol, not verapamil, in combination with digoxin is the treatment of choice in chronic atrial fibrillation.
Topics: Atrial Fibrillation; Chronic Disease; Digoxin; Drug Therapy, Combination; Humans; Pindolol; Verapamil | 1989 |
Anti-arrhythmic effects of LB-46 on experimentally produced digitoxic arrhythmias.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Digoxin; Dogs; Female; Male; Pindolol | 1972 |
LB-46 in cardiac arrhythmias.
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Digoxin; Female; Heart Rate; Humans; Male; Middle Aged; Pindolol; Tachycardia; Tachycardia, Paroxysmal | 1972 |
Management of patients with chronic atrial fibrillation.
Topics: Adult; Aged; Atrial Fibrillation; Chronic Disease; Circadian Rhythm; Digitoxin; Digoxin; Drug Therapy, Combination; Heart Rate; Humans; Medigoxin; Middle Aged; Pindolol; Propranolol | 1982 |
Effect of pacing rate and intensity on mechanical alternans amplitude.
Topics: Animals; Calcium Gluconate; Cardiac Pacing, Artificial; Digoxin; Dogs; Electrocardiography; Epinephrine; Heart Auscultation; Heart Rate; Heart Sounds; Pindolol | 1981 |